This funding opportunity supports exploratory research projects aimed at advancing and validating emerging technologies with improved technical capabilities for cancer biology, early detection, diagnosis, treatment, control, and epidemiology. Projects must demonstrate preliminary feasibility data and focus on further development and rigorous validation to promote adoption by the cancer research community. Clinical trial applications are not allowed.
Eligible applicants include a wide range of U.S. government entities, educational institutions, nonprofits, for-profit organizations, small businesses, tribal governments, and foreign institutions. Specific eligibility details are provided in the full announcement.
